Insider filing · MLTX
da Silva Jorge Santos
Chief Executive Officer
profile →
MoonLake Immunotherapeutics
MLTX · Healthcare · 18 filings in 24 months
ticker →
da Silva Jorge Santos sold $3.0M of MoonLake Immunotherapeutics (MLTX)
Executed Dec 8 2025, disclosed Dec 10 2025, 2 days later.
Value, as filed
$3.0M
200,000 sh across 2 lots
Executed
Dec 8 2025
the trade date, as filed
Disclosed
Dec 10 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DSda Silva Jorge Santos (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $3.0M of MLTX (200,000 sh across 2 lots, as filed), executed Dec 8 2025.
The name
MLTXHealthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by da Silva Jorge Santos in MLTX
MLTXSALE
MoonLake Immunotherapeutics
$2.0M102,225 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 4:10 PM ET MLTXSALE MoonLake Immunotherapeutics $957K
47,775 sh × $20.03
Exec Jul 1
Filed Jul 2 · 4:10 PM ET MLTXSALE MoonLake Immunotherapeutics $2.8M
150,000 sh across 2 lots
Exec Apr 10
Filed Apr 14 · 5:30 PM ET